Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q4 2019 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2020-02-11

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q4 2019 (Next →)

Filing Date: Feb 11, 2020

Total Value: $163M (100.0% shares, 0.0% debt)

Holdings (4)

— SYNTHORX INC 43.1%

Value $70.25M Shares 1,005,184 Share Price $69.89 Est. Cost/Share $69.89 Unrealized @ Report Date —

PHAT PHATHOM PHARMACEUTICALS INC 39.5%

Value $64.39M Shares 2,067,861 Share Price $31.14 Est. Cost/Share $25.13 Unrealized @ Report Date +23.9%

— MERUS N V 13.8%

Value $22.53M Shares 1,600,000 Share Price $14.08 Est. Cost/Share $14.08 Unrealized @ Report Date —

— OBSEVA SA 3.7%

Value $5.997M Shares 1,570,000 Share Price $3.82 Est. Cost/Share $3.82 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	SYNTHORX INC	1,005,184	$70.25M	43.1%	$69.89	$69.89	—	COM	87167A103
PHAT	PHATHOM PHARMACEUTICALS INC	2,067,861	$64.39M	39.5%	$31.14	$25.13	+23.9%	COM	71722W107
—	MERUS N V	1,600,000	$22.53M	13.8%	$14.08	$14.08	—	COM	N5749R100
—	OBSEVA SA	1,570,000	$5.997M	3.7%	$3.82	$3.82	—	COM	H5861P103